TP53 and non-small cell lung carcinoma: Our results further demonstrated that knocking down DCP1B partially mitigates the tumor-inhibitory effect of p53 by increasing MAPK4 expression, and overexpression of MAPK4 stimulates the proliferation and migration of NSCLC cells partially by counteracting the effect of DCP1B.